Funded Trading Plus $25,000 Account Review: Price, Rules & Verdict

Account Rules & Specs

Cost Breakdown

The Funded Trading Plus $25,000 account sits in an awkward position - it has some appealing features but significant limitations that make it hard to recommend over transparent competitors. Let's break down whether this account deserves your money. The most glaring issue is the undisclosed pricing. While FundedNext charges $199.99 for their $25K challenge and FTMO charges $250, Funded Trading Plus doesn't publish their fees upfront. This lack of transparency immediately puts them at a disadvantage, as you can't properly evaluate the cost-to-benefit ratio that's crucial for prop firm selection. Looking at the trading rules, there are both positives and negatives. The 10% profit target in Phase 1 matches FTMO's requirement, which is standard but not particularly generous compared to FundedNext's 8% target. However, the absence of a Phase 2 profit target is interesting - once you're funded, you can focus purely on consistent profits rather than hitting arbitrary targets. The risk management rules present a mixed bag. The 4% daily loss limit (balance-based) is actually tighter than most competitors who offer 5%, which could be problematic if you're used to taking larger position sizes. On a $25,000 account, this means you can only lose $1,000 in a single day before being disqualified. For comparison, a 5% daily loss would give you $1,250 breathing room. The 6% trailing total loss limit is more restrictive than the industry standard 10%. On your funded account, this means once you've made any profit, your maximum allowable loss from your highest balance point is just $1,500. This trailing mechanism can be particularly challenging for swing traders who might experience normal drawdowns of 3-4% during winning trades. One major advantage is the weekly payout frequency. While many firms pay monthly or bi-weekly, getting paid every week can significantly improve your cash flow, especially important if you're treating this as primary income. The 80% profit split with scaling to 100% is standard industry practice. The platform selection is solid with MT5, cTrader, DxTrade, and Match Trade options, giving you flexibility in execution. However, the 1:30 leverage limit on forex may frustrate scalpers who rely on higher leverage for their strategies. Here's where things get problematic: you can only trade forex. No indices, commodities, crypto, or stocks. This is a severe limitation in 2026 when most successful prop traders diversify across multiple asset classes. If you want to trade US30, NASDAQ, Gold, or Bitcoin alongside your EUR/USD positions, you'll need to look elsewhere. The firm does allow news trading 'subject to policy' which is better than FTMO's restrictions, and weekend holding is permitted. However, EAs and copy trading are prohibited, eliminating automated strategies entirely. For the challenge approach, focus on consistent small wins rather than trying to hit the 10% target quickly. With the tighter daily loss limits, position sizing becomes critical. Consider risking no more than 0.8% per trade to ensure you can take multiple losing trades without hitting the 4% daily limit. The scaling opportunity up to $2.5 million is appealing for long-term growth, but you need to prove consistency first. Given the restrictive loss limits, this may take longer than with more lenient competitors. Compared to alternatives, FundedNext offers more flexibility with multiple asset classes and transparent pricing at $199.99. FTMO, while slightly more expensive at $250, provides the same multi-asset trading with a proven track record and higher loss limits. Unless you're specifically seeking a forex-only environment with weekly payouts and can verify their pricing is competitive, this account doesn't offer compelling advantages over established competitors. The combination of undisclosed pricing, asset restrictions, and tighter loss limits makes it difficult to recommend as a first choice for most traders.

Alternatives to Consider

Frequently Asked Questions

Related